Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

March 30, 2021

Study Completion Date

April 16, 2021

Conditions

RSV Infection

Interventions

DRUG

EDP-938

Subjects will receive EDP-938 once daily on Days 1 and 14

DRUG

Fluconazole

Subjects will receive fluconazole once daily on Days 5 to 18

Trial Locations (1)

Pharmaceutical Research Associates, Inc.,, Salt Lake City